Small RNA Profiling in an HTLV-1-Infected Patient with Acute Adult T-Cell Leukemia-Lymphoma at Diagnosis and after Maintenance Therapy: A Case Study

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorPESSOA, Rodrigo
dc.contributor.authorSOUZA, Daniela Raguer Valadao de
dc.contributor.authorNUKUI, Youko
dc.contributor.authorPEREIRA, Juliana
dc.contributor.authorFERNANDES, Lorena Abreu
dc.contributor.authorMARCUSSO, Rosa Nascimento
dc.contributor.authorOLIVEIRA, Augusto Cesar Penalva de
dc.contributor.authorCASSEB, Jorge
dc.contributor.authorDUARTE, Alberto Jose da Silva
dc.contributor.authorSANABANI, Sabri Saeed
dc.date.accessioned2023-08-16T17:45:26Z
dc.date.available2023-08-16T17:45:26Z
dc.date.issued2023
dc.description.abstractSmall RNAs (sRNAs) are epigenetic regulators of essential biological processes associated with the development and progression of leukemias, including adult T-cell leukemia/lymphoma (ATLL) caused by human T-cell lymphotropic virus type 1 (HTLV-1), an oncogenic human retrovirus originally discovered in a patient with adult T-cell leukemia/lymphoma. Here, we describe the sRNA profile of a 30-year-old woman with ATLL at the time of diagnosis and after maintenance therapy with the aim of correlating expression levels with response to therapy.eng
dc.description.indexMEDLINE
dc.description.indexPubMed
dc.description.indexWoS
dc.description.indexScopus
dc.description.sponsorshipFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2022/09354-9]
dc.identifier.citationINTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, v.24, n.13, article ID 10643, 15p, 2023
dc.identifier.doi10.3390/ijms241310643
dc.identifier.eissn1422-0067
dc.identifier.issn1661-6596
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/54552
dc.language.isoeng
dc.publisherMDPIeng
dc.relation.ispartofInternational Journal of Molecular Sciences
dc.rightsopenAccesseng
dc.rights.holderCopyright MDPIeng
dc.subjectsmall RNAeng
dc.subjectHTLV-1eng
dc.subjectATLLeng
dc.subjectmassive parallel sequencingeng
dc.subject.othervirus type-1 taxeng
dc.subject.otherkappa-b pathwayeng
dc.subject.otherc-mybeng
dc.subject.othertumor-suppressoreng
dc.subject.otherdown-regulationeng
dc.subject.otherexpressioneng
dc.subject.othermicrornaeng
dc.subject.othergeneeng
dc.subject.otheractivationeng
dc.subject.othertransactivationeng
dc.subject.wosBiochemistry & Molecular Biologyeng
dc.subject.wosChemistry, Multidisciplinaryeng
dc.titleSmall RNA Profiling in an HTLV-1-Infected Patient with Acute Adult T-Cell Leukemia-Lymphoma at Diagnosis and after Maintenance Therapy: A Case Studyeng
dc.typearticleeng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.author.externalPESSOA, Rodrigo:Fed Univ Sao Paulo UNIFESP, Dept Med, Postgrad Program Translat Med, BR-04039002 Sao Paulo, Brazil
hcfmusp.author.externalSOUZA, Daniela Raguer Valadao de:Fed Univ Sao Paulo UNIFESP, Dept Med, Postgrad Program Translat Med, BR-04039002 Sao Paulo, Brazil
hcfmusp.author.externalFERNANDES, Lorena Abreu:Fed Univ Sao Paulo UNIFESP, Dept Med, Postgrad Program Translat Med, BR-04039002 Sao Paulo, Brazil
hcfmusp.author.externalMARCUSSO, Rosa Nascimento:Emilio Ribas Inst Infectol, Dept Neurol, BR-01246900 Sao Paulo, Brazil
hcfmusp.author.externalOLIVEIRA, Augusto Cesar Penalva de:Emilio Ribas Inst Infectol, Dept Neurol, BR-01246900 Sao Paulo, Brazil
hcfmusp.citation.scopus0
hcfmusp.contributor.author-fmusphcYOUKO NUKUI
hcfmusp.contributor.author-fmusphcJULIANA PEREIRA
hcfmusp.contributor.author-fmusphcJORGE SIMAO DO ROSARIO CASSEB
hcfmusp.contributor.author-fmusphcALBERTO JOSE DA SILVA DUARTE
hcfmusp.contributor.author-fmusphcSABRI SAEED MOHAMMED ALSANABANI
hcfmusp.description.articlenumber10643
hcfmusp.description.issue13
hcfmusp.description.volume24
hcfmusp.origemWOS
hcfmusp.origem.pubmed37445821
hcfmusp.origem.scopus2-s2.0-85164844694
hcfmusp.origem.wosWOS:001030870800001
hcfmusp.publisher.cityBASELeng
hcfmusp.publisher.countrySWITZERLANDeng
hcfmusp.relation.referenceAgha DM, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21197065eng
hcfmusp.relation.referenceAgirre X, 2008, MOL CANCER RES, V6, P1830, DOI 10.1158/1541-7786.MCR-08-0167eng
hcfmusp.relation.referenceAl Sharif S, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12121422eng
hcfmusp.relation.referenceAmbros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803eng
hcfmusp.relation.referenceAriumi Y, 2000, ONCOGENE, V19, P1491, DOI 10.1038/sj.onc.1203450eng
hcfmusp.relation.referenceBatlle E, 2019, IMMUNITY, V50, P924, DOI 10.1016/j.immuni.2019.03.024eng
hcfmusp.relation.referenceBazarbachi A, 1999, BLOOD, V93, P278, DOI 10.1182/blood.V93.1.278.401k22_278_283eng
hcfmusp.relation.referenceBazarbachi A, 2011, BLOOD, V118, P1736, DOI 10.1182/blood-2011-03-345702eng
hcfmusp.relation.referenceBender TP, 2004, NAT IMMUNOL, V5, P721, DOI 10.1038/ni1085eng
hcfmusp.relation.referenceChang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30eng
hcfmusp.relation.referenceChang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106eng
hcfmusp.relation.referenceClissa PB, 2016, DATA BRIEF, V9, P685, DOI 10.1016/j.dib.2016.09.052eng
hcfmusp.relation.referenceD'Agostino DM, 2022, FRONT IMMUNOL, V13, DOI 10.3389/fimmu.2022.974088eng
hcfmusp.relation.referenceDatta A, 2006, BLOOD, V108, P1021, DOI 10.1182/blood-2006-01-0067eng
hcfmusp.relation.referenceDjebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233eng
hcfmusp.relation.referenceDong N, 2014, MOL CELL BIOCHEM, V396, P229, DOI 10.1007/s11010-014-2158-4eng
hcfmusp.relation.referenceEl-Sabban ME, 2000, BLOOD, V96, P2849eng
hcfmusp.relation.referenceELDEIRY WS, 1994, CANCER RES, V54, P1169eng
hcfmusp.relation.referenceFarazi TA, 2008, DEVELOPMENT, V135, P1201, DOI 10.1242/dev.005629eng
hcfmusp.relation.referenceFranchini Genoveffa, 2000, Hematology Am Soc Hematol Educ Program, P409eng
hcfmusp.relation.referenceFulci V, 2007, BLOOD, V109, P4944, DOI 10.1182/blood-2006-12-062398eng
hcfmusp.relation.referenceGessain A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00388eng
hcfmusp.relation.referenceGorur A, 2013, MOL BIOL REP, V40, P2091, DOI 10.1007/s11033-012-2267-7eng
hcfmusp.relation.referenceGottmann P, 2018, MOL METAB, V11, P145, DOI 10.1016/j.molmet.2018.03.005eng
hcfmusp.relation.referenceHachiman M, 2018, ONCOL LETT, V16, P1305, DOI 10.3892/ol.2018.8771eng
hcfmusp.relation.referenceHansen KD, 2012, BIOSTATISTICS, V13, P204, DOI 10.1093/biostatistics/kxr054eng
hcfmusp.relation.referenceHiguchi C, 2015, METABOLISM, V64, P489, DOI 10.1016/j.metabol.2014.12.003eng
hcfmusp.relation.referenceHiguchi M, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-117eng
hcfmusp.relation.referenceHudson RS, 2013, ONCOGENE, V32, P4139, DOI 10.1038/onc.2012.424eng
hcfmusp.relation.referenceHuntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936eng
hcfmusp.relation.referenceInoshita S, 1999, KIDNEY INT, V56, P1238, DOI 10.1046/j.1523-1755.1999.00705.xeng
hcfmusp.relation.referenceJazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105eng
hcfmusp.relation.referenceJiang X, 2012, CANCER CELL, V22, P524, DOI 10.1016/j.ccr.2012.08.028eng
hcfmusp.relation.referenceKan T, 2009, GASTROENTEROLOGY, V136, P1689, DOI 10.1053/j.gastro.2009.02.002eng
hcfmusp.relation.referenceKim BG, 2021, J HEMATOL ONCOL, V14, DOI 10.1186/s13045-021-01053-xeng
hcfmusp.relation.referenceKIM SJ, 1990, J EXP MED, V172, P121, DOI 10.1084/jem.172.1.121eng
hcfmusp.relation.referenceLee J, 2019, BREAST CANCER RES TR, V176, P119, DOI 10.1007/s10549-019-05192-1eng
hcfmusp.relation.referenceLi BK, 2014, DIAGN PATHOL, V9, DOI 10.1186/s13000-014-0226-4eng
hcfmusp.relation.referenceLi CY, 2019, CHINESE MED J-PEKING, V132, P2213, DOI 10.1097/CM9.0000000000000427eng
hcfmusp.relation.referenceLi JQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099442eng
hcfmusp.relation.referenceLi NN, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.119eng
hcfmusp.relation.referenceLi Y, 2009, CANCER SCI, V100, P1234, DOI 10.1111/j.1349-7006.2009.01164.xeng
hcfmusp.relation.referenceLin SL, 2008, RNA, V14, P417, DOI 10.1261/rna.874808eng
hcfmusp.relation.referenceLin XC, 2017, INT J ONCOL, V50, P671, DOI 10.3892/ijo.2016.3832eng
hcfmusp.relation.referenceLu L, 2019, J CANCER, V10, P3389, DOI 10.7150/jca.31676eng
hcfmusp.relation.referenceLuo KX, 1997, EMBO J, V16, P1970, DOI 10.1093/emboj/16.8.1970eng
hcfmusp.relation.referenceMarcuello M, 2019, CANCERS, V11, DOI 10.3390/cancers11101542eng
hcfmusp.relation.referenceMarquez ME, 2022, CANCERS, V14, DOI 10.3390/cancers14071676eng
hcfmusp.relation.referenceMattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046eng
hcfmusp.relation.referenceMotsch N, 2007, RNA BIOL, V4, P131, DOI 10.4161/rna.4.3.5206eng
hcfmusp.relation.referenceMu DZ, 2002, J CELL BIOL, V157, P493, DOI 10.1083/jcb.200109100eng
hcfmusp.relation.referenceMURPHY EL, 1989, INT J CANCER, V43, P250, DOI 10.1002/ijc.2910430214eng
hcfmusp.relation.referenceNabhan M, 2017, GENE, V628, P253, DOI 10.1016/j.gene.2017.07.052eng
hcfmusp.relation.referenceNagata Y, 2016, BLOOD, V127, P596, DOI 10.1182/blood-2015-06-644948eng
hcfmusp.relation.referenceNahand JS, 2020, IUBMB LIFE, V72, P343, DOI 10.1002/iub.2222eng
hcfmusp.relation.referenceNakano K, 2016, CLIN CANCER RES, V22, P5915, DOI 10.1158/1078-0432.CCR-15-1739eng
hcfmusp.relation.referenceNascimento A, 2021, INFECT AGENTS CANCER, V16, DOI 10.1186/s13027-020-00343-2eng
hcfmusp.relation.referenceNasr R, 2003, BLOOD, V101, P4576, DOI 10.1182/blood-2002-09-2986eng
hcfmusp.relation.referenceNicot C, 2001, MOL CELL BIOL, V21, P7391, DOI 10.1128/MCB.21.21.7391-7402.2001eng
hcfmusp.relation.referenceNIITSU Y, 1988, BLOOD, V71, P263eng
hcfmusp.relation.referenceOoi A, 2017, HUM PATHOL, V61, P58, DOI 10.1016/j.humpath.2016.10.025eng
hcfmusp.relation.referencePeng QL, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-06863-9eng
hcfmusp.relation.referencePichler K, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-100eng
hcfmusp.relation.referencePise-Masison CA, 2000, MOL CELL BIOL, V20, P3377, DOI 10.1128/MCB.20.10.3377-3386.2000eng
hcfmusp.relation.referencePOIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415eng
hcfmusp.relation.referenceSAKASHITA A, 1992, BLOOD, V79, P477eng
hcfmusp.relation.referenceSampath D, 2009, BLOOD, V113, P3744, DOI 10.1182/blood-2008-09-178707eng
hcfmusp.relation.referenceSHIMOYAMA M, 1991, BRIT J HAEMATOL, V79, P428, DOI 10.1111/j.1365-2141.1991.tb08051.xeng
hcfmusp.relation.referenceSi WG, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-018-0587-8eng
hcfmusp.relation.referenceSun G, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/687826eng
hcfmusp.relation.referenceTanha HM, 2016, TUMOR BIOL, V37, P7861, DOI 10.1007/s13277-015-4553-1eng
hcfmusp.relation.referenceTomita M, 2012, INT J CANCER, V130, P2300, DOI 10.1002/ijc.25115eng
hcfmusp.relation.referenceUngefroren H, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-67eng
hcfmusp.relation.referencede Souza DRV, 2020, ONCOL LETT, V20, P2311, DOI 10.3892/ol.2020.11803eng
hcfmusp.relation.referencevan Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089eng
hcfmusp.relation.referenceVasilatou D, 2010, EUR J HAEMATOL, V84, P1, DOI 10.1111/j.1600-0609.2009.01348.xeng
hcfmusp.relation.referenceVerboon LJ, 2016, ONCOTARGET, V7, P48412, DOI 10.18632/oncotarget.10270eng
hcfmusp.relation.referenceVerdonck K, 2007, LANCET INFECT DIS, V7, P266, DOI 10.1016/S1473-3099(07)70081-6eng
hcfmusp.relation.referenceWang F, 2015, ONCOL LETT, V10, P11, DOI 10.3892/ol.2015.3170eng
hcfmusp.relation.referenceWang XH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002557eng
hcfmusp.relation.referenceWang XD, 2018, GENE, V665, P6, DOI 10.1016/j.gene.2018.04.065eng
hcfmusp.relation.referenceWatanabe A, 2011, LEUKEMIA, V25, P1324, DOI 10.1038/leu.2011.81eng
hcfmusp.relation.referenceXu Ling, 2011, Zhonghua Xue Ye Xue Za Zhi, V32, P178eng
hcfmusp.relation.referenceXu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1eng
hcfmusp.relation.referenceYamada Y, 2001, BRIT J HAEMATOL, V113, P375, DOI 10.1046/j.1365-2141.2001.02737.xeng
hcfmusp.relation.referenceYamagishi M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00334eng
hcfmusp.relation.referenceYang TS, 2014, FEBS LETT, V588, P2162, DOI 10.1016/j.febslet.2014.04.050eng
hcfmusp.relation.referenceYeung ML, 2008, CANCER RES, V68, P8976, DOI 10.1158/0008-5472.CAN-08-0769eng
hcfmusp.relation.referenceYOSHIDA M, 1984, P NATL ACAD SCI-BIOL, V81, P2534, DOI 10.1073/pnas.81.8.2534eng
hcfmusp.relation.referenceYu D, 2014, LAB INVEST, V94, P1370, DOI 10.1038/labinvest.2014.125eng
hcfmusp.relation.referenceYu SR, 2017, ANTI-CANCER DRUG, V28, P852, DOI 10.1097/CAD.0000000000000524eng
hcfmusp.relation.referenceYuan C, 2019, ONCOL LETT, V18, P1979, DOI 10.3892/ol.2019.10495eng
hcfmusp.relation.referenceZanette DL, 2007, BRAZ J MED BIOL RES, V40, P1435, DOI 10.1590/S0100-879X2007001100003eng
hcfmusp.relation.referenceZhang MY, 2021, BLOOD, V138, DOI 10.1182/blood-2021-152517eng
hcfmusp.relation.referenceZhang WC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11702eng
hcfmusp.relation.referenceZhao TJ, 2011, BLOOD, V118, P1865, DOI 10.1182/blood-2010-12-326199eng
hcfmusp.relation.referenceZheng LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055719eng
hcfmusp.relation.referenceZheng RH, 2015, J SURG RES, V195, P158, DOI 10.1016/j.jss.2014.12.035eng
hcfmusp.scopus.lastupdate2024-06-21
relation.isAuthorOfPublication5db14723-eed0-4bd2-8e34-c8743bb42b5f
relation.isAuthorOfPublication58959854-e2e3-4246-9a9e-ca4b771aa16f
relation.isAuthorOfPublicationdb8fd0fe-568d-426b-b59b-955d4d21c0a9
relation.isAuthorOfPublication8e4f2c15-06a5-444b-826d-84576403144e
relation.isAuthorOfPublicationac11205a-1d60-4244-83ea-c4d0162033c6
relation.isAuthorOfPublication.latestForDiscovery5db14723-eed0-4bd2-8e34-c8743bb42b5f
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
art_PESSOA_Small_RNA_Profiling_in_an_HTLV1Infected_Patient_with_2023.PDF
Tamanho:
2.86 MB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)